首页> 美国卫生研究院文献>The Journal of Physiology >Cytochrome P450 mono-oxygenase-regulated signalling of Ca2+ entry in human and bovine endothelial cells.
【2h】

Cytochrome P450 mono-oxygenase-regulated signalling of Ca2+ entry in human and bovine endothelial cells.

机译:细胞色素P450单加氧酶调节人和牛内皮细胞中Ca2 +进入的信号传导。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. We tested the hypothesis that agonist-stimulated Ca2+ entry, and thus formation of endothelium-derived nitric oxide (EDNO) in vascular endothelial cells, is related to activation of microsomal P450 mono-oxygenase (P450 MO) and the biosynthesis of 5,6-epoxyeicosatrienoic acid (5,6-EET). 2. Several P450 inhibitors diminished the sustained [Ca2+]i plateau response to agonist or intracellular Ca2+ store depletion with ATPase inhibitors by 31-69% (fura-2 technique). Mn2+ influx stimulated by agonists or ATPase inhibitors was prevented by P450 inhibitors. 3. Histamine- or ATPase inhibitor-stimulated formation of EDNO was strongly attenuated (50-83%) by P450 inhibitors, without any effect on EDNO formation by the Ca2+ ionophore A23187, indicating that decreased EDNO synthesis is due specifically to the inhibition of Ca2+ entry by these compounds. 4. Induction of P450 MO by beta-naphthoflavone potentiated agonist-induced Ca2+ and Mn2+ influx by 60 and 53%, respectively. Intracellular Ca2+ release remained unchanged. 5. The P450 MO product, 5,6-EET (< 156 nmol l-1), activated Ca2+/Mn2+ entry without any depletion of intracellular Ca2+ stores. The 5,6-EET-stimulated Ca2+/Mn2+ entry was not affected by P450 inhibitors. 6. As with the bradykinin-stimulated Ca2+ entry pathway, the 5,6-EET-activated Ca2+ entry pathway was permeable to Mn2+ and Ba2+, sensitive to Ni2+, La3+ and membrane depolarization, and insensitive to the removal of extracellular Na+ or the organic Ca2+ antagonist, nitrendipine. 7. In the presence of 5,6-EET, stimulation with bradykinin only transiently increased [Ca2+]i. Vice versa, 5,6-EET failed to increase [Ca2+]i further in bradykinin-stimulated cells. The sustained [Ca2+]i plateau phase induced by a co-stimulation with bradykinin and 5,6-EET was identical to that observed with bradykinin or 5,6-EET alone. 8. These results demonstrate that Ca2+ entry induced by the P450 MO product, 5,6-EET, is indistinguishable to that observed by stimulation with bradykinin. 9. All data support our hypothesis that depletion of endothelial Ca2+ stores activates microsomal P450 MO which in turn synthesizes 5,6-EET. We propose that the arachidonic acid metabolite 5,6-EET or one of its metabolites is a second messenger for activation of endothelial Ca2+ entry.
机译:1.我们测试了以下假设:激动剂刺激Ca2 +进入,从而在血管内皮细胞中形成内皮源性一氧化氮(EDNO)与微粒体P450单加氧酶(P450 MO)的激活和5的生物合成有关。 6-环氧二十碳三烯酸(5,6-EET)。 2.几种P450抑制剂可减少对ATPase抑制剂对激动剂或细胞内Ca2 +储存耗竭的持续[Ca2 +] i平台反应,降低31-69%(fura-2技术)。激动剂或ATPase抑制剂刺激的Mn2 +流入被P450抑制剂阻止。 3. P450抑制剂可强烈抑制组胺或ATPase抑制剂刺激的EDNO形成(50-83%),而Ca2 +离子载体A23187对EDNO的形成没有任何影响,表明EDNO合成减少是由于Ca2 +的抑制所致这些化合物进入。 4.由β-萘黄酮增强的激动剂诱导的Ca 2+和Mn 2+的流入分别诱导P450 MO 60%和53%。细胞内Ca 2+释放保持不变。 5. P450 MO产物5,6-EET(<156 nmol 1-1)激活了Ca2 + / Mn2 +进入,而细胞内Ca2 +存储没有任何消耗。 5,6-EET刺激的Ca2 + / Mn2 +进入不受P450抑制剂的影响。 6.与缓激肽刺激的Ca2 +进入途径一样,5,6-EET激活的Ca2 +进入途径对Mn2 +和Ba2 +具有渗透性,对Ni2 +,La3 +和膜去极化敏感,对去除细胞外Na +或有机物不敏感Ca2 +拮抗剂,尼群地平。 7.在5,6-EET存在下,缓激肽刺激只会使[Ca2 +] i暂时增加。反之亦然,在缓激肽刺激的细胞中,5,6-EET无法进一步增加[Ca2 +] i。与缓激肽和5,6-EET共同刺激诱导的持续[Ca2 +] i平台期与单独使用缓激肽或5,6-EET观察到的相同。 8.这些结果表明,由P450 MO产物5,6-EET诱导的Ca2 +进入与缓激肽刺激所观察到的没有区别。 9.所有数据均支持我们的假设,即内皮Ca2 +储存的耗尽会激活微粒体P450 MO,进而合成5,6-EET。我们建议,花生四烯酸代谢物5,6-EET或其代谢物之一是激活内皮Ca2 +进入的第二信使。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号